Analytical Control of Allogeneic CAR-T Therapies: NGS-Based Assays for Genomic Integrity Assessment

Time: 11:30 am
day: Conference Day Two


  • Development of comprehensive control strategies to ensure genome integrity in CRISPR-Cas editing cell therapies
  • Short and Long read NGS assays for characterization of on-and off-target editing
  • Implementation of NGS-based analytical workflows